Keystone Heart, A Venus Medtech Company, Announces First Commercial Case Performed Worldwide with the TriGUARD 3™ Cerebral Embolic Protection Device
- Wednesday, July 29, 2020, 7:09
- Finance
- Add a comment
TAMPA, Fla., July 29, 2020 /PRNewswire/ — Keystone Heart, LTD., a medical device innovator driven to redefine the standard of structural heart care, today announced completion of the first worldwide commercial case using the TriGUARD 3™ Cerebral Embolic Protection (CEP) Device. Pieter…
About the Author
adminasapcorp has written 41528 stories on this site.